World Preview 2024: Pharma’s Growth Boost
Key assumptions underpinning the pharmaceutical sector are being tested.
Foreword
Pharma’s Growth Boost
Big Drugs for Big Diseases
Wegovy and Zepbound are Just the Start
Pipeline Captures CNS Revival
More M&A as Public Markets Remain Flat
Pharma R&D Spend Grows More Slowly
HOW WE HELP
Thanks for reading!
Contact us for more information